|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/12 | |
| A61K 31/497 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3386975 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16813274.4 |
| Europos patento paraiškos padavimo data | 2016-12-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/064379 |
| Data | 2016-12-01 |
| (87) | Numeris | WO 2017/100071 |
| Data | 2017-06-15 |
| (30) | Numeris | Data | Šalis |
| 201562263908 P | 2015-12-07 | US |
| (72) |
ENNETT-SHEPARD, Alessandra B., US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | 5-(5-(2-(3-AMINOPROPOXY)-6-METHOXYPHENYL)-1H-PYRAZOL-3-YLAMINO)PYRAZINE-2-CARBONITRILE (S)-LACTATE MONOHYDRATE |
| 5-(5-(2-(3-AMINOPROPOXY)-6-METHOXYPHENYL)-1H-PYRAZOL-3-YLAMINO)PYRAZINE-2-CARBONITRILE (S)-LACTATE MONOHYDRATE |